Loading clinical trials...
Loading clinical trials...
Prospective Assessment of Dasatinib Management Among CP-CML Patients With Dasatinib Initiation in a Real Life Setting: DasaREALISE.
Conditions
Interventions
Non-Interventional
Locations
1
France
Local Institution
Paris, France
Start Date
April 21, 2016
Primary Completion Date
January 16, 2020
Completion Date
January 16, 2020
Last Updated
June 21, 2022
NCT06514534
NCT05143840
NCT06994676
NCT06523556
NCT06236724
NCT04195633
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions